Welcome to Breast Cancer Online
Breast Cancer Online (BCO) aims to facilitate timely access to new trends and topical information in breast cancer for healthcare professionals.
Mission statement: "Breast Cancer Online (BCO) aims to facilitate timely access to new trends and topical information in breast cancer for healthcare professionals."
BCO is a peer-reviewed educational service made available free to users working in the numerous fields of breast cancer research and treatment. The content of the website is invited and reviewed by an independent international editorial board of experts from a multi-disciplinary perspective.

This site is intended for healthcare professionals and as such may contain information not intended or suitable for patients. For this reason we ask interested readers to register for usage and in doing so to confirm professional status. If you are looking for information aimed at patients, please have a look at the Patient Information section for more appropriate information.

We hope you find BCO to be a valuable resource that you will come to use on a regular basis. When registering, please remember to opt for our newsletter and contents update features.

Recent articles have included:
Ductal carcinoma in situ of the breast – an overview of the randomized clinical trials
Ph. Meijnen, E. J. Th. Rutgers
Modelling and analysis of DCIS detection and reduction in invasive carcinoma - a review
S. W. Duffy
Validation of transgenic models of breast cancer: ductal carcinoma in situ (DCIS) and Brca1-mutation-related breast cancer
M. S. Frech, L. P. Jones, P. A. Furth
Minimally invasive approaches: cryoablation
T. L. Huston, R. M. Simmons
Implication of planned radiotherapy on breast reconstruction: radiotherapy and plastic surgery with implants
G. M. Freedman
Estrogen receptor acetylation and phosphorylation in hormone responses
C. Wang, M. Fu, R. G. Pestell
Shift in the surgical treatment of non-palpable breast cancer: tactile to visual
K. Dowlatshahi, J. Dieschbourg
New opportunities in premenopausal breast cancer: goserelin (‘Zoladex’) plus aromatase inhibition
R. Jakesz
Management of lesions first detected on MRI: what to do?
L. Bartella, E. A. Morris
The role of disseminated and circulating tumour cells in breast cancer
D. Auer, A. Schneitter, C. Marth, S. Braun
Therapeutic Mammotome excision of fibroadenomas
A. J. Maxwell
Role of plasma membrane ER protein in breast cancer
E. M. Rosen, S. Fan, Y. Ma, E. R. Levin
Accelerated partial breast irradiation: 3-dimensional conformal external beam radiotherapy
Y. Hasan, F. Vicini
The role of platinum-based therapy for HER-2-positive breast cancer
A. A. Joy, J. R. Mackey
Alcohol drinking and breast cancer
Duan-Jun Tan, Julie S. Barber, Peter G. Shields
Micrometastasis in lymph node
S. Masood
Pre-operative endocrine therapy: focus on the clinical and biological results of the IMPACT trial
R. L. Jones, I. E. Smith
Ultrasound elasticity imaging
W. E. Svensson, D. Amiras
Modest benefits of adjuvant chemotherapy in hormone receptor-positive breast cancer
Tiffany H. Svahn, Robert W. Carlson
Growth factor pathway switching: implications for the use of gefitinib and trastuzumab
H. E. Jones, JMW Gee, I.R. Hutcheson, RI Nicholson
The role of surgery for pulmonary metastases in breast cancer patients
D. A. Hess, H. M. Klomp
Should positive sentinel node cases have a further axillary dissection?
Blake Cady